ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.Play
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Providing federal and commercial clients with services to help them develop vaccines, drugs, diagnostics and medical devices.
ICON understands the unique requirements of medical devices, diagnostics, and combination drug/device and biologic/device products.